Finance

Lists
Why is 4588 down 3,24%?
Dive Deeper
4588:TYO
Oncolys Biopharma Inc
5 970,00 JP¥
-3,24%
(-200,00) 1D
9 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4588...
Open
6 150 JP¥
High
6 390 JP¥
Low
5 760 JP¥
Mkt. cap
176,18 մլրդ
Avg. vol.
1,91 մլն
Volume
1,10 մլն
52-wk high
7 020 JP¥
52-wk low
668 JP¥
EPS
-54 JP¥
Shares outstanding
13,14 մլն
No. of employees
45
Open
6 150 JP¥
High
6 390 JP¥
Low
5 760 JP¥
Mkt. cap
176,18 մլրդ
Avg. vol.
1,91 մլն
Volume
1,10 մլն
52-wk high
7 020 JP¥
52-wk low
668 JP¥
EPS
-54 JP¥
Shares outstanding
13,14 մլն
No. of employees
45
News stories
From web sources and news partners
About Oncolys Biopharma Inc
CEO-
Employees45
Founded18 մրտ, 2004 թ.
Headquarters-
Sector-
Websiteoncolys.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. հնս
2025 թ. սեպ
2026 թ. մրտ
2026 թ. հնս
Revenue
28,55 մլն
-
3,09 մլն
500,00 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
510,47 մլն
303,94 մլն
423,81 մլն
846,89 մլն
Operating expense
511,47 մլն
305,01 մլն
423,81 մլն
849,46 մլն
Total operating expenses
511,47 մլն
305,01 մլն
423,81 մլն
849,46 մլն
Operating income
-482,92 մլն
-305,01 մլն
-420,72 մլն
-349,46 մլն
Other non operating income
13,00 հզր
-8,69 մլն
-2,14 մլն
-62,00 հզր
EBT including unusual items
-500,86 մլն
-302,92 մլն
-413,36 մլն
-347,24 մլն
EBT excluding unusual items
-500,86 մլն
-302,92 մլն
-413,36 մլն
-347,24 մլն
Income tax expense
713,00 հզր
891,00 հզր
1,12 մլն
430,00 հզր
Effective tax rate
-0,14%
-0,29%
-0,27%
-0,12%
Other operating expenses
-
-
-
-
Net income
-501,58 մլն
-303,81 մլն
-414,48 մլն
-347,67 մլն
Net profit margin
-1 757,08%
-
-13 413,66%
-69,53%
Earnings per share
-
-
-
-
Interest and investment income
479,00 հզր
1,52 մլն
3,04 մլն
199,00 հզր
Interest expense
-1,20 մլն
-1,51 մլն
-2,99 մլն
-5,85 մլն
Net interest expenses
-725,00 հզր
10,00 հզր
58,00 հզր
-5,65 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-482,90 մլն
-304,80 մլն
-420,71 մլն
-349,42 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps